Medigene : Annual Report 2022 Presentation
Pioneering Differentiated TCR-T Therapies for Cancer Patients FY 2022 Financial Results and Corporate Update Forward Looking... | March 30, 2023
United States San Diego Hongsheng Sciences Development Optimization While The Company Patient Immune Monitoring Development Optimization
Source: marketscreener.com